Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies.
Huang J, Alexey S, Li J, Jones T, Grande G, Douthit L, Xie J, Chen D, Wu X, Michael M, Xiao C, Zhao J, Xie X, Xie J, Chen XL, Fu G, Alexander G, Tzeng CM.
Huang J, et al. Among authors: tzeng cm.
Leukemia. 2019 Sep;33(9):2315-2319. doi: 10.1038/s41375-019-0455-3. Epub 2019 Apr 8.
Leukemia. 2019.
PMID: 30962578
No abstract available.